Newsletter Archive

1. 09.29.22 -- Affinity Chromatography For Bispecific Antibodies And Fragments 9/29/2022

   09/29/22 Drug Discovery Online Newsletter

2. 09.28.22 -- Power Your Drug Discovery With Modeling And Simulation 9/28/2022

   09/28/22 Drug Discovery Online Newsletter

3. 09.28.22 -- The Fundamentals Of Developing mRNA-Based Therapeutics: Key Stages, Process Development, And Scale-Up 9/28/2022

   09/28/22 Drug Discovery Online Newsletter

4. 09.27.22 -- Rapid Method Development To Overcome Challenges Of Bi-Specific Antibody Purification 9/27/2022
   09/27/22 Drug Discovery Online Newsletter
5. 09.22.22 -- Planning For Outsourced Drug Development Shifts 9/22/2022

   09/22/22 Drug Discovery Online Newsletter

6. 09.21.22 -- Adapting To Change: Drug Development, Manufacturing, And Supply 9/21/2022

   09/21/22 Drug Discovery Online Newsletter

7. 09.20.22 -- Mitigating Hidden Risks: Extractables And Leachables 9/20/2022
   09/20/22 Drug Discovery Online Newsletter
8. 09.15.22 -- Integrated Solutions Facilitate AAV Manufacturing 9/15/2022

   09/15/22 Drug Discovery Online Newsletter

9. 09.15.22 -- Biopharma Leaders Address Resilient Biomanufacturing Capacity Needs 9/15/2022
   09/15/22 Drug Discovery Online Newsletter
10. 09.13.22 -- Align CMC Strategy With Clinical Path Requirements And Timelines 9/13/2022
    09/13/22 Drug Discovery Online Newsletter